| Ytd | -18.18% | |
| 1y | -81.16% |
| Open | 1.65 | Prev Close | 1.66 | Low | 1.59 | High | 1.69 | Mkt Cap | 116.79M |
| Vol | 1.02M | Avg Vol | 836.44K | EPS | -0.17 | P/E | N/A | Forward P/E | 272.00 |
| Beta | 1.62 | Short Ratio | 8.67 | Inst. Own | 73.27% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 08-25 | Earning | 11-09 | 50-d Avg | 2.78 | 200-d Avg | 3.18 | 1yr Est | 6.75 |
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investor
Palo Alto Networks' Prisma AIRS tops $100 million in ARR, with rapid customer adoption highlighting
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve
[url="]Schall, Brown and Schwartz[/url] LLP (âSBSâ), a national shareholder rights litigation fi
LOS ANGELES--(BUSINESS WIRE)---- $AIRS--AIRS Investors Have Opportunity to Join AirSculpt Technologi
NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investor
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve
NEW YORK, Sept. 10, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investor
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgery.
NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inve
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
AirSculpt Technologies NASDAQ: AIRS is seeing stabilization in its core body-contouring business aft
AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call Transcript
Gainers Jin Medical International (NASDAQ:ZJYL) shares rose 58.1% to $3.4 during Monday's regul
US stocks mixed, Dow Jones down 0.2% midday. Energy shares up 3%, real estate down 1.4%. National En
AirSculpt Technologies NASDAQ: AIRS reported second-quarter revenue of $42.9 million, down 2.5% from
Dow Jones fell 0.2% as US stocks opened lower. Energy shares rose 1.9%, while real estate stocks dro
Gainers Jin Medical International (NASDAQ:ZJYL) stock rose 70.7% to $3.67 during Monday's pre-m
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday.
Summary: U.S. stock futures mixed, Dow futures down 0.1%. AirSculpt Technologies shares fell 13.4% a
AirSculpt Technologies (NASDAQ:AIRS) narrows FY2026 sales outlook from $151.000 million-$157.000 mil
Gainers Replimune Group (NASDAQ:REPL) shares increased by 134.6% to $12.69 during Friday's pre-
U.S. stock futures rise, Nasdaq 100 up 300 points. Apple Inc shares fall 7.4% despite beating analys
Amazon reported strong Q2 results, beating revenue and earnings estimates. Shares jumped 11.9% in pr
AirSculpt Technologies (NASDAQ:AIRS) affirms FY2026 sales outlook from $151.000 million-$157.000 mil
AirSculpt Technologies (NASDAQ:AIRS) reported quarterly losses of $(0.01) per share which beat the a
AirSculpt Technologies (NASDAQ:AIRS) affirms Q1 sales outlook from $38.500 million-$39.500 million t
AirSculpt Technologies (NASDAQ:AIRS) sees FY2026 sales of $151.000 million-$157.000 million vs $156.
AirSculpt Technologies (NASDAQ:AIRS) reported quarterly losses of $(0.02) per share which beat the a
AirSculpt stock rebounds after steep drop as delayed filing, weak revenue, and 2026 outlook raise in
AirSculpt Technologies (NASDAQ:AIRS) lowers preliminary FY2025 sales outlook from $153.000 million t
AirSculpt Technologies (NASDAQ:AIRS) sees Preliminary Q1 sales of $38.500 million-$39.500 million vs